INFORMATION AND SERVICES EXCLUSIVELY FOR US HEALTHCARE PROFESSIONALS

BEXSERO®

BEXSERO is contraindicated in cases of hypersensitivity, including severe allergic reaction, to any component of the vaccine, or after a previous dose of BEXSERO

...continue reading

Between 99 and 188 cases of meningococcal group B disease occurred annually in patients <1 to ≥65 years of age in the US between 2008 and 2013 (0.03-0.06/100,000 population)."toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"[1] Up to 1 in 5 survivors of meningococcal disease will suffer from sequelae."toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"[2]

BEXSERO may not provide protection against all meningococcal serogroup B strains.

Click below to hear Rayna's story, a survivor of meningococcal disease.

References

"toolbar=yes, scrollbars=yes, resizable=yes, width=400, height=400,top=50, left=50"View all references

709301R0 May 2016